#1
|
|||
|
|||
Íóæíî ëå÷èòü ùåëî÷íóþ ôîñôàòàçó?
Çäðàâñòâóéòå. Ïîñîâåòóéòå, ïîæàëóéñòà, êàê èíòåðïðåòèðîâàòü è ÷òî äåëàòü ñî ñëó÷àéíî îáíàðóæåííûì ïîâûøåíèåì ùåëî÷íîé ôîñôàòàçû ó ìàëü÷èêà 12 ëåò.
Ñåé÷àñ áåç æàëîá, èíîãäà íåîáúÿñíèìàÿ áîëü â êîëåíå, âåñíîé ïîëëèíîç íà áåðåçó (+ÀÑÈÒ). Çà ïîñëåäíåå âðåìÿ òðè ðàçíûõ (è ñ ðàçíûìè ðåôåðåíñíûìè èíòåðâàëàìè) ðåçóëüòàòà èññëåäîâàíèÿ íà ùåëî÷íóþ ôîñôàòàçó: Êîä:
24.08.2021 725 [108-702] ÅÄ/ë 11.11.2021 328 [42-362] ÅÄ/ë 10.12.2021 401 [42-362] ÅÄ/ë |
#2
|
||||
|
||||
óâåëè÷åíèå íåçíà÷èòåëüíîå.Ó ðàñòóùèõ ìàëü÷èêîâ ùåëî÷íàÿ ôîñôàòàçà âûøå , ÷åì ó âçðîñëûõ.Ïðè îòñóòñâèè æàëîá, íàõîäîê ïðè îñìîòðå è äðóãèõ èçìåíåíèé â àíàëèçàõ êðîâè íèêàêèå äåéñòâèÿ ïðåäïðèíèìàòü íå íàäî.Ìîæåò ñòîèò ïîäàâàòü ïðîôèëàêòè÷åñêóþ äîçó âèò.Ä
|
#3
|
|||
|
|||
Ñïàñèáî áîëüøîå çà îòâåò!
Öèòàòà:
Öèòàòà:
Âîò åùå ïîñëåäíÿÿ ÝÊÃ Êîä:
Îïèñàíèå: ×ÑÑ=55-69 â ìèíóòó PQ=0,12, QRS=0,08, QT=0,38, QTc=0,36-0,41 ðèòì ñèíóñîâûé. Çàêëþ÷åíèå: Âûðàæåííàÿ ñèíóñîâàÿ áðàäèêàðäèÿ, ëåãêàÿ àðèòìèÿ. Âåðòèêàëüíàÿ ÝÎÑ. Ñèíäðîì ðàííåé ðåïîëÿðèçàöèè æåëóäî÷êîâ. ÝÊà â ïðåäåëàõ âîçðàñòíîé íîðìû. Öèòàòà:
|
#4
|
||||
|
||||
Îò âèò Äý (500ÌÅ/ñóòêè) õóæå íå áóäåò òî÷íî
|
#5
|
|||
|
|||
Ñïàñèáî! Ñ íàñòóïàþùèì íîâûì ãîäîì!
|
#6
|
||||
|
||||
áûñòðî-ðàñòóøèå äåòè ñ ðîñòîì áîëåå 180 íå äîñòèãíó 18 ëåò ïëþñ íåâûñîêèé âåñ ïëþñ îäèí èç ðîäèòåëåé òàêîé æåæ = ìîæåò áûòü ðèñê Ìàðôàíà â ñåìüå èëè äð. çàáîëåâàíèé ñîåä. òêàíè, ïðîâåðüòå ñèìïòîìû ïî êàëüêóëÿòîðó [Ññûëêè äîñòóïíû òîëüêî çàðåãèñòðèðîâàííûì ïîëüçîâàòåëÿì ]
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#7
|
|||
|
|||
Öèòàòà:
Ïîïðîáóþ îòâåòèòü äëÿ ìàëü÷èêà 12 ëåò, ìàññîé 38.7 êã, è ðîñòîì 157ñì (ìàìà 175ñì, ïàïà 183ñì): LS=80cm, US=77cm, US/LS=0.96 Armspan=151cm Armspan/height=0.96
Íå çíàþ, âàæíî ëè ýòî, íî âðîæäåííàÿ ñîåä.òêàííàÿ äèñïëàçèÿ ó ýòîãî ðåáåíêà îáñóæäàëàñü ðàíåå. |
|
#8
|
||||
|
||||
Systemic Score=3- íè÷åãî íå íàäî ïðè òàêîì ïîêàçàòåëå
|
#9
|
||||
|
||||
â çàâèñèìîñòè îò òîãî, ÷òî íåäîîáñëåäîâàíî è êàêèå áàëëû ìîãóò áûòü - âîïðîñ îòêðûò
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#10
|
|||
|
|||
Èçâèíèòå, ðàñïèøó ïîäðîáíî ïî ïóíêòàì:
|
#11
|
||||
|
||||
ïîõîæå, ÷òî ðèñê íåâåëèê, íî åòî êëàññè÷åñêèé Ìàðôàí, áûâàþò àòèïè÷íûå ôîðìû èëè æå äðóãàÿ ïàòîëîãèÿ ñîåä. òêàíè, äëÿ êîòîðîé ïîêà íåò êàëüêóëÿòîðîâ ðèñêà
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#12
|
||||
|
||||
atypical Marfan syndrome (MFS): had some Marfanoid features, did not meet the Ghent criteria for MFS, and/or were FBN1 negative
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#13
|
||||
|
||||
äîáàâëþ, ÷òî ìîè ñóæäåíèÿ áûëè äëÿ äåâî÷êè 14 ëåò, ó êîòîðîé ðîñò óæå 180 ñì, íîðìà ðîñòà äëÿ äåâî÷åê â 14-15 ëåò (97 ïåðöåíòèëü) 173 ñì, â áîëüøèíñòâå ñëó÷àåâ - ýòî êîíñòèòóö. âûñîêîðîñëîñòü, íî èíîãäà - ïàòîëîãèÿ:
Tall stature is usually defined as a height beyond 97th percentile or more than 2 SD above the mean height for age and sex in a defined population. Familial tall stature, also known as constitutional tall stature, is the most common cause of tall stature... Tall stature by itself is not a pathological condition, however, there are a number of disorders associated with tall stature. Some genetic disorders and syndromes may be associated with mental retardation and various complications. Therefore, recognition of tall stature and revealing the underlying pathogenic causes and making the diagnosis are important not to miss the serious conditions and to provide adequate medical care and genetic counseling. Pathological causes for tall statute include endocrine disorders, such as excessive growth hormone secretion, hyperthyroidism, precocious puberty and lipodystrophy, chromosome disorders, such as Trisomy X (47, XXX female), Klinefelter Syndrome (47, XXY), XYY syndrome (47, XYY male) and fragile X syndrome, and syndromes and metabolic disorders, such as Marfan Syndrome, Beckwith-Wiedemann Syndrome, Simpson-Golabi-Behmel Syndrome, Sotos Syndrome and homocystinuria. --- Minerva Pediatr. 2020 Dec;72(6):472-483. Tall stature in children and adolescents
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |
#14
|
|||
|
|||
Âàäèì Âàëåðüåâè÷, íàâåðíîå, ÿ òîãäà ëó÷øå îòêðîþ îòäåëüíóþ òåìó ïðî äî÷êó?
Ïî ïîâîäó ìàëü÷èêà 12 ëåò, íà âñÿêèé ñëó÷àé, ÿ ïðàâèëüíî ïîíÿë, ÷òî:
Åùå ðàç áîëüøîå ñïàñèáî! |
#15
|
||||
|
||||
êàê ïðèìåð èç ãîëë. ñòàòüè î 19-òè ïîäðîñòêàõ ñ Ìàðôàíîì: ó âñåõ ïîäòâåðæäåííûé äèàãíîç ãåíåòè÷åñêè, ÍÎ òîëüêî ó ïîëîâèíû êàëüêóëÿöèÿ ðèñêà ïîêàçàëà 7 èëè áîëåå áàëëîâ
Gender (male/female) = 12/7 Age (range) (years) = 14.5 (12–17) Confirmed pathogenic FBN1 variant = 19 Systemic Ghent score ≥ 7 = 10
__________________
Èñêðåííå, Âàäèì Âàëåðüåâè÷. |